Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 7 of 7 for “"X-linked inhibitor of apoptosis protein (XIAP)"”.

  1. Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder

    X-linked inhibitor of apoptosis protein (XIAP) is associated with tumor genesis, growth, progression and metastasis, and acts by blocking caspase-mediated apoptosis. In the present study, we sought to evaluate the expression patterns of XIAP in various neoplastic thyroid disorders and determine the …

    ajou Repository record for Expression of X-linked Inhibitor of Apoptosis Protein in Neoplastic Thyroid Disorder (opens in a new tab)

  2. Characterisation of a protease-dependent gene regulation system for gene therapy applications

    … is a promising approach for the treatment of a wide range of chronic diseases. These therapies typically utilise strong, constitutively active promoters to drive high levels of recombinant protein expression. Unregulated gene expression is a key issue limiting clinical translation of

    auckland-ms Repository record for Characterisation of a protease-dependent gene regulation system for gene therapy applications (opens in a new tab)

  3. Role of X-Linked Inhibitor of Apoptosis Protein in Therapeutic Resistance of Inflammatory Breast Cancer Cells

    <p>Apoptotic dysregulation is a hallmark of cancer cells. The inability of cancer cells to undergo apoptosis may lead to therapeutic resistance. Inflammatory breast cancer (IBC) is a highly aggressive subtype of breast cancer that is often characterized by ErbB2 overexpression and ErbB2 activation. …

    duke Repository record for Role of X-Linked Inhibitor of Apoptosis Protein in Therapeutic Resistance of Inflammatory Breast Cancer Cells (opens in a new tab)

  4. Investigating a novel small molecule inhibitor of nuclear import as an anti-cancer approach

    The identification of novel cancer-associated biomarkers against which drugs can be developed is anticipated to be beneficial in multiple ways; including their use as monotherapies and in combination with current chemotherapeutic agents for improved anti-cancer treatment outcome. Recently, research …

    cape-town Repository record for Investigating a novel small molecule inhibitor of nuclear import as an anti-cancer approach (opens in a new tab)

  5. Nanotherapies for Treating Prostate Cancer

    … physiological barriers which hinder efficacy of anticancer agents. Therefore, the focus of this study was to investigate a new combination therapy approach for treating prostate cancer and develop polymeric nanocarriers to facilitate anticancer drug and nucleic acid delivery.</p> <p>It was …

    tenn-hsc Repository record for Nanotherapies for Treating Prostate Cancer (opens in a new tab)

  6. Discovery of Inhibitors of Inhibitors of Apoptosis Proteins and Novel Tubulin Polymerization Inhibitors as Potential Anticancer Agents

    <p>The global impact of cancer as a significant public health concern is undeniable. According to the annual report by the American Cancer Society, projections for 2023 estimate 1,958,310 new cancer cases and 609,820 cancer-related deaths in the US. Recent years have seen significant progress in …

    tenn-hsc Repository record for Discovery of Inhibitors of Inhibitors of Apoptosis Proteins and Novel Tubulin Polymerization Inhibitors as Potential Anticancer Agents (opens in a new tab)

  7. Advances in high-throughput screening: better compounds, novel targets, enhanced sensors

    … in modern drug discovery. Through the evaluation of large structure collections, novel drug leads can be rapidly assessed for modulation of medicinally-relevant biological targets. This occurs through the interplay of three intrinsically linked facets, namely A) the chemical collections being …

    uiuc Repository record for Advances in high-throughput screening: better compounds, novel targets, enhanced sensors (opens in a new tab)